The Role of Autophagy in Pancreatic Cancer Development

A recent study published in the journal Developmental Cell has highlighted the role of autophagy in the development of pancreatic cancer. This research was funded by Cancer Research UK, with additional support from the Medical Research Council and the Biotechnology and Biological Sciences Research Council.

New Discoveries About Pancreatic Cells

Researchers from the Cancer Research UK center in Scotland studied pancreatic cells in mice over time to understand why healthy cells turn cancerous. They found that pancreatic cells at risk of becoming cancerous, known as precancerous cells, develop defects in the cellular recycling process known as autophagy.

In these precancerous cells, researchers observed the formation of clumps of misfolded protein molecules, a behavior seen in neurological diseases like dementia. They also noted similar clustering in human pancreatic samples, suggesting this occurs during the development of pancreatic cancer.

The Role of Autophagy in Diseases

Autophagy is a vital process in the body that breaks down excess molecules no longer needed. In the pancreas, autophagy is particularly important for controlling the levels of proteins and digestive hormones produced by the pancreas to aid in food breakdown.

Over the years, scientists have studied autophagy in detail and learned about its critical role in diseases such as cancer. In some cases, cancer cells may become “addicted” to autophagy, hijacking the recycling process to help them divide and grow more rapidly.

The Link Between Genes and Autophagy

Research suggests that the combined effect of a dysfunctional KRAS gene and impaired autophagy could drive the development of pancreatic cancer. Researchers plan to study these processes in more detail to see if they can help predict or potentially reverse the onset of pancreatic cancer, and whether factors like age, gender, or diet play a role.

Although survival rates for many types of cancer have improved over recent decades, this has not been the case for pancreatic cancer. This is partly because it is often diagnosed at a late stage, where treatment options are limited.

Conclusion

Research into pancreatic cancer is a priority for Cancer Research UK, with funding directed towards understanding the causes of pancreatic cancer, diagnostic tests, and clinical trials designed to improve treatment, reduce side effects, and manage symptoms. This new research shows how a better understanding of pancreatic cancer development can open up new opportunities for prevention and treatment.